Infarmed investigates Janssen vaccines after fainting episodes in Mafra – Coronavirus

Infarmed announced this evening that it is investigating the quality of Janssen vaccines made available at the Covid-19 Vaccination Center in Mafra after patients passed out after taking the Janssen vaccine.

In a short statement sent to the newsrooms, the national authority of the medicine explains that the measures come “following the cases of adverse reactions (syncope), notified with the Janssen vaccine, at the vaccination center in Mafra”.

According to that health authority, “so far, suspicions of a defect in the quality of this batch have not been reported in other vaccination centers where it is being used”.

“Infarmed decided to start a process of investigation of the quality of the remaining units of the vaccine at that place of vaccination, as well as suspending this batch until the necessary investigations are concluded”, he adds.

The latest official figures indicate that more than 42% of Portuguese people have completed vaccination and 60% have taken at least one dose. This week alone, more than one million doses have been administered, the highest since the start of the covid-19 vaccination campaign.

The covid-19 pandemic has caused at least 4,053,041 deaths worldwide, among more than 187.7 million cases of infection by the new coronavirus, according to the most recent balance sheet by the Agence France-Presse.

In Portugal, since the beginning of the pandemic, in March 2020, 17,182 people have died and 916,559 cases of infection have been registered, according to the Directorate-General for Health.

The respiratory disease is caused by the SARS-CoV-2 coronavirus, detected in late 2019 in Wuhan, a city in central China, and currently with variants identified in countries such as the United Kingdom, India, South Africa, Brazil and Peru.

Source: Jornal de Negócios by

*The article has been translated based on the content of Jornal de Negócios by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!